Researchers have used a drug screening platform they developed to show that an antidepressant, currently on the market, kills tumor cells in the dreaded glioblastoma -- at least in the cell-culture ...

Being told you have cancer is like a dark cloud over your life. It’s tough, no matter the type of cancer. Every day feels ...

Tocilizumab -- an interleukin (IL)-6 receptor inhibitor -- was approved by the FDA in 2017 for the treatment of severe or ...

There is a challenge related to prostate and many other cancers that cancer cells form resistance to treatments as the disease progresses. However, these resistance mechanisms are not yet fully ...

Researchers at Saint Louis University School of Medicine investigated differences in T-cell responses between male and female ...

Hetronifly in combination with chemotherapy was shown to improve survival of patients with extensive stage small cell lung ...

Treatment-resistant cells are a challenge related to prostate cancer and many other cancers, which arises as the disease ...

IBCN annual meeting included a keynote lecture by Dr. Niko Beerenwinkel discussing inferring tumor evolution from single-cell data. Although the majority of work has been done in other cancers (ie.

Interested in the spatial research landscape, technological breakthroughs and future directions? Check out this interview ...

Due to the remarkable success of the Research Topic 'New Insights in Veterinary Cancer Immunology' and the rapidly evolving subject area, we are pleased to launch Volume II for this topic. The tumour ...

The highly anticipated 2024 European Society for Medical Oncology (ESMO) Annual Congress has taken place from September 13 to 17 in Barcelona, Spain. As one of the most influential annual gatherings ...

InnoCare Pharma gets Chinese nod to begin clinical trial of BCL2 inhibitor ICP-248 for acute myeloid leukaemia: Beijing Friday, September 20, 2024, 18:00 Hrs [IST] InnoCare Pharma ...